Study implicates the role of epigenetic enzyme in Crohn's disease
Researchers at Massachusetts General Hospital (Boston, MA, USA) have highlighted how a variant in an epigenetic enzyme interferes with the action of the innate immune system and intestinal health. These findings provide possible treatment routes for inflammatory bowel diseases.
Please sign in or register for FREE to view this content
Sign in to EpigenomicsNet
Register to EpigenomicsNet – the epigenetics and epigenomics network
EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.